Sort   by:  
 Page size 
UnknownMethylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
Not available
S-EPMC6162272 | biostudies-literature
UnknownBRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Not available
S-EPMC11299415 | biostudies-literature
UnknownDeregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
Not available
S-EPMC3076323 | biostudies-literature
UnknownPrognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370 | biostudies-literature
UnknownMyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Not available
S-EPMC5870793 | biostudies-literature
UnknownBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Not available
S-EPMC3387216 | biostudies-literature
UnknownVirtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders.
Not available
S-EPMC7450410 | biostudies-literature
Sort   by:  
 Page size